Outlook for the next 5 years in drug innovation
Nature Reviews Drug Discovery 11, 435 (2012).
Authors: Roy Berggren, Martin Møller, Rachel Moss, Pawel Poda & Katarzyna Smietana
Analysis of industry pipeline data and revenue forecasts highlights several trends in the anticipated output of new drugs and the therapeutic area focus over the next 5 years, including a growth in the average number of new drug approvals annually.
Category: Latest Medication News